Sign in

Research summary ·

Moxibustion combinations for diabetic peripheral neuropathy: a network meta-analysis of 40 randomised trials.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at moxibustion for nerve damage caused by diabetes. Moxibustion is an outside-the-body treatment from Chinese medicine. The team pooled 40 trials with 3,718 people in total. In each trial, people were put into groups by chance. The team compared moxibustion alone and with other care. Added care included acupuncture, massage, or herbs by mouth or on skin. The trials also used usual care as a comparison. The team checked how fast nerves send signals. They also checked symptom scores and how many people clearly got better.

What they found

Moxibustion with herbs on the skin did well against usual care. With this mix, signals moved faster in several nerves. In one nerve, the gain was 6.14 m/s. Scores for symptoms and signs also went down with this mix. The proof was of moderate strength for that gain and that score drop. Moxibustion with acupuncture sped up signals in one sensory nerve. Both mixes led to more people with a clear good response.

What it means for patients

The authors say moxibustion with skin herbs may help nerve signals. It may also ease the symptoms and signs of this nerve damage. More people may have a clear good response with it. The authors think moxibustion mixes may be a useful add-on. They mean an add-on to standard, conservative care for this nerve damage. They do not claim the benefit is sure.

Why it is not certain yet

The authors say stronger trials still need to confirm these results. Their main conclusion rests on proof of moderate strength. For one sensory nerve result, the strength ranged from moderate to very low. The abstract does not give the strength for every result. It also does not report on side effects. A review can only be as good as the studies in it.

Source

Moxibustion combinations for diabetic peripheral neuropathy: a network meta-analysis of 40 randomised trials.

PubMed · PMID 42755773

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Diabetic neuropathy publications